Monopar Therapeutics Inc.
MNPR
$41.91
-$1.24-2.87%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 900.19% | -15.43% | -19.04% | 21.02% | -14.47% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 59.07% | -18.69% | -48.74% | 79.22% | -9.29% |
Total Current Assets | 893.31% | -15.46% | -19.44% | 21.55% | -14.42% |
|
|||||
Total Current Assets | 893.31% | -15.46% | -19.44% | 21.55% | -14.42% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -49.80% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 893.31% | -15.46% | -19.44% | 21.34% | -14.52% |
|
|||||
Total Accounts Payable | 100.76% | 3.07% | -24.09% | -18.33% | -11.32% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 367.92% | 3.07% | -24.09% | -18.33% | -11.32% |
|
|||||
Total Current Liabilities | 367.92% | 3.07% | -24.09% | -18.33% | -11.32% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 367.92% | 3.07% | -24.09% | -18.33% | -11.32% |
|
|||||
Common Stock & APIC | 87.32% | 0.26% | 0.47% | 5.34% | 1.24% |
Retained Earnings | -16.84% | -2.05% | -2.77% | -2.73% | -3.11% |
Treasury Stock & Other | 427.27% | -232.53% | 97.62% | 129.79% | -461.54% |
Total Common Equity | 1,012.57% | -18.78% | -18.55% | 33.81% | -15.48% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1,012.57% | -18.78% | -18.55% | 33.81% | -15.48% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 1,012.57% | -18.78% | -18.55% | 33.81% | -15.48% |
|